Clinical Trial Update: R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas [Phase 2]

View source ↗

Summary

This is a completed Phase 2 clinical trial evaluating the R-MegaCHOP-ESHAP-BEAM regimen in high-risk aggressive B-cell lymphomas, including Diffuse Large B-Cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mediastinal B-cell Lymphoma

Drugs mentioned

• R-MegaCHOP-ESHAP-BEAM

Snippet

Sponsor: Czech Lymphoma Study Group | Conditions: Diffuse Large B-Cell Lymphoma., Primary Mediastinal B-Cell Lymphoma | Phase 2 | Status: COMPLETED